The Department of Human Medicine for Cardiology offers two PhD positions at the University of Oldenburg for the academic session 2021-2022.
The European Medical School is a cooperation of Oldenburg University with its cooperating hospitals and the University of Groningen with its University Hospital UMCG. Beyond their collaboration in the development of a medical school, the institutions also develop shared research activities.
Table of Contents
Summary
| Scholarship Sponsor | The University of Oldenburg |
| Scholarships level | PhD Position |
| Award Amount | Not Specified |
| Fellowship Period | Three years |
| Study area | Health Life Sciences |
| Opening date | February 19, 2021 |
| Closing date | March 10, 2021 |
Project Description
Using a translational approach, the group addresses scientific questions about inflammatory responses to stressors with a particular focus on the cardiovascular system. In vitro and in vivo preclinical models are used as much as samples from registries and clinical studies to gain insight into pathophysiology and mechanisms of diseases related to the cardiovascular system.
Our group is devoted to publishing our results in the finest journals that can be reached and primarily finance the work through grant money. The formal language of the group is English. The colleagues’ task will be to take on and carry out projects together with the Postdocs of the group related to cardiovascular medicine.
A prerequisite for the positions is the successful completion of an academic university degree (Master or equivalent) in biology, biochemistry, molecular biology, or a neighbouring discipline with a focus on immunology, cardiovascular disease or inflammation. Also, broad experience in patient-oriented basic science is considered very relevant, reflected by relevant publications and previous projects.
One of the projects is dealing with vascular complications in response to perioperative inflammatory stress and focusing on the dynamic change of the vulnerability of atheromata (project atherosclerosis).
The other project focuses on the role of protein tyrosine phosphatase receptors in heart failure and their role in cardiac remodelling (project heart failure).
Application Deadline
The deadline for applications is March 10, 2021
Eligibility
We expect:
- Experience in cellular and molecular biology
- Willingness to perform preclinical studies using in vivo models in small rodents
- Fluent oral and written communication skill in English
- Basic knowledge in Dutch and German or the willingness to acquire these skills
- Interpersonal communication skills and the ability to work both independently and in a group
- Self-motivation, creativity, genuine curiosity, work discipline, professional ethics, and ambition
What you can expect:
- Close and intense supervision and support
- Membership in a dynamic interdisciplinary team
- The vibrant international academic environment
- Professionally stimulating ambient
- Direct working contacts with our cooperation partners in The Netherlands, Sweden, Belgium and the USA
- Completion of a high-quality PhD
The University of Oldenburg is dedicated to increasing the percentage of female employees in the field of science. Therefore, female candidates are strongly encouraged to apply. According to § 21, 3 NHG female applicants must be preferably considered in case of equal qualification.
Applicants with disabilities will be given preference in case of equal qualification.
Application Process
Please send your application (indicating heart failure or atherosclerosis), including an academic CV, full publication list, an application letter stating your scientific work and interests, as well as a personal assessment of how you fit the description of the person we seek and the name and contact details of three references as one compressed file (pdf) to [email protected] until 10.03.2021 or by mail to Prof. Dr Theilmeier, Peri-2xi, Dept.
Human Medicine, Faculty of Medicine and Health Sciences, University of Oldenburg, W02C, Carl von Ossietzky Str. 9-11, 26129 Oldenburg. Your application by e-mail is preferred. Please contact us via e-mail in case you have any questions or need further information.
